Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Acer Therapeutics Inc. | CHIEF LEGAL OFFICER AND SECRETARY | Employee Stock Option (right to buy) | 30K | Mar 14, 2023 | Direct | ||
ACHIEVE LIFE SCIENCES, INC. | Director | Stock Option (right to buy) | 4.4K | May 31, 2022 | Direct | ||
Acer Therapeutics Inc. | CHIEF LEGAL OFFICER AND SECRETARY | Common Stock, $0.0001 par value per share | 0 | Nov 17, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ACER | Acer Therapeutics Inc. | Nov 17, 2023 | 1 | $0 | 4 | Nov 20, 2023 | CHIEF LEGAL OFFICER AND SECRETARY |
ACER | Acer Therapeutics Inc. | Mar 14, 2023 | 1 | $0 | 4 | Mar 16, 2023 | Chief Legal Officer and Secy |
ACHV | ACHIEVE LIFE SCIENCES, INC. | May 31, 2022 | 1 | $0 | 4 | Jun 1, 2022 | Director |
ACER | Acer Therapeutics Inc. | Jan 14, 2022 | 1 | $0 | 4 | Jan 19, 2022 | Chief Legal Officer and Secy |
ACHV | ACHIEVE LIFE SCIENCES, INC. | May 11, 2021 | 1 | $0 | 4 | May 13, 2021 | Director |